Dynatronics Corporation (DYNT): Price and Financial Metrics

DYNT Stock Price Chart Interactive Chart >

DYNT Price/Volume Stats

Dynatronics Corporation (DYNT) Company Bio

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. It offers orthopedic soft bracing products, which include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also provides power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, recumbent bikes, and other related equipment. In addition, it offers therapeutic modality devices, such as electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. Further, the company provides clinical supplies, including exercise bands and tubing, topical analgesics, lotions and gels, orthopedic bracing, paper products, athletic tapes, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, and athletic trainers, sports medicine practitioners, hospitals, clinics, and consumers, as well as online. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Eagan, Minnesota.

DYNT Price Forecast Based on DCF Valuation

We started the process of determining a valid price forecast for Dynatronics Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Dynatronics Corp ranked in the 8th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Dynatronics Corp, consider:

• The compound growth rate in the free cash flow of Dynatronics Corp over the past 5.63 years is -0.21%; that's better than only 8.3% of cash flow producing equities in the Healthcare sector, where it is classified.
• Dynatronics Corp's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 22.05% of US stocks with positive free cash flow.
• Dynatronics Corp's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -11.9. This coverage rate is greater than that of only 6.18% of stocks we're observing for the purpose of forecasting via discounted cash flows.

PRGO, ANGO, PAHC, SNN, and ATRS can be thought of as valuation peers to DYNT, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.